Mylan Enters Generic Biologicals Market
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 7 (Table of Contents)
Published: 16 Jul-2009
DOI: 10.3833/pdr.v2009.i7.1136 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
US-based generics company, Mylan, has tied up with the Indian biotech company, Biocon, to develop, manufacture and commercialise high value generic biological drugs for the global market...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS